adenocarcinoma of the prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Radical prostatectomy
Item
underwent prior radical prostatectomy as local definitive therapy for prostate cancer
boolean
C0194810 (UMLS CUI [1])
androgen blockade therapy (either single-agent luteinizing hormone-releasing hormone or combined androgen blockade)
Item
has received ≥ 9 months of androgen blockade therapy (either single-agent luteinizing hormone-releasing hormone or combined androgen blockade) for serologic progression after surgery
boolean
C1518041 (UMLS CUI [1])
C3495882 (UMLS CUI [2])
rising prostate-specific antigen; no objective evidence of metastatic disease
Item
serologic progression defined as a rising prostate-specific antigen, which has risen serially on two determinations (from baseline) ≥ 1 week apart, and no objective evidence of metastatic disease
boolean
C0201544 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Radiotherapy
Item
prior radiotherapy for serologic progression allowed
boolean
C1522449 (UMLS CUI [1])
androgen blockade therapy
Item
did not receive any form of androgen blockade therapy within the past 9 months
boolean
C0279492 (UMLS CUI [1])
no metastatic disease by abdominal/pelvic ct scan and whole-body scan
Item
no metastatic disease by abdominal/pelvic ct scan and whole-body scan
boolean
C0027627 (UMLS CUI [1,1])
C0203669 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1641132 (UMLS CUI [2,2])
CT scan
Item
able to tolerate ct scanning in the supine position
boolean
C0040405 (UMLS CUI [1])
medical condition affecting the thymus, including myasthenia gravis, lymphoma, hyperthyroidism, or cachexia
Item
no prior medical condition known to have effects on the thymus, including myasthenia gravis, lymphoma, hyperthyroidism, or cachexia
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0040113 (UMLS CUI [1,3])
C0026896 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0020550 (UMLS CUI [4])
C0006625 (UMLS CUI [5])
autoimmune disorders
Item
no autoimmune disorders
boolean
C0004364 (UMLS CUI [1])
no acute illness, including active infection
Item
no acute illness, including active infection requiring antibiotics
boolean
C0001314 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
concurrent therapy
Item
prior concurrent therapy: see disease characteristics
boolean
C0009429 (UMLS CUI [1])
systemic chemotherapy
Item
no prior systemic chemotherapy
boolean
C1883256 (UMLS CUI [1])
immunological therapy
Item
no prior immunological therapy
boolean
C0021083 (UMLS CUI [1])
antiandrogen
Item
no prior single-agent antiandrogen (e.g., high-dose bicalutamide)
boolean
C0002842 (UMLS CUI [1])
5-alpha reductase inhibitors, pc-spes, or estrogen-containing nutraceuticals
Item
no prior or concurrent 5-alpha reductase inhibitors (e.g., finasteride), pc-spes, or estrogen-containing nutraceuticals
boolean
C2936788 (UMLS CUI [1])
C0756934 (UMLS CUI [2])
C0014939 (UMLS CUI [3])
systemic steroids
Item
no concurrent systemic steroid therapy (topical steroids allowed)
boolean
C2825233 (UMLS CUI [1])